Grace Cherry
Impact in
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Cancer Cells and Metastasis
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 11
-
- Acute Kidney Injury Research 1
- Co-authors
- Bartosz Chmielowski (4 shared papers)Antoni Ribas (5 shared papers)Willy Hugo (3 shared papers)Roger S. Lo (3 shared papers)Siwen Hu‐Lieskovan (3 shared papers)Jesse Meir Zaretsky (3 shared papers)Beata Berent-Maoz (3 shared papers)Mark C. Kelley (2 shared papers)
- Journals
- Nature (2 papers)Cell (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Seminars in Oncology Nursing (1 paper)Kidney International (1 paper)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Grace Cherry
13 papers receiving 12.5k citations
Grace Cherry's Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 9.4k
- Immunology 1.7k
- Cancer Research 655
- Pulmonary and Respiratory Medicine 831
- Genetics 205
Countries citing papers authored by Grace Cherry
This map shows the geographic impact of Grace Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Cherry more than expected).
Fields of papers citing papers by Grace Cherry
This network shows the impact of papers produced by Grace Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Cherry. The network helps show where Grace Cherry may publish in the future.
Co-authors
The 25 scholars most cited alongside Grace Cherry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 blockade induces responses by inhibiting adaptive immune resistance Hit paper breakdown → | 2014 | 5584 |
| 2 | Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma Hit paper breakdown → | 2016 | 2716 |
| 3 | Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma Hit paper breakdown → | 2016 | 2628 |
| 4 | Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations Hit paper breakdown → | 2016 | 1112 |
| 5 | 2017 | 344 | |
| 6 | 2023 | 128 | |
| 7 | Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations | 2017 | 105 |
| 8 | 2018 | 32 | |
| 9 | 2017 | 24 | |
| 10 | 2015 | 16 | |
| 11 | 2022 | 10 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 4 |
About Grace Cherry
Grace Cherry is a scholar working on Oncology, Nephrology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Nuclear Energy and Engineering, having authored 13 papers that have together received 12.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Chemotherapy-induced organ toxicity mitigation (1 paper), Acute Kidney Injury Research (1 paper) and Adrenal Hormones and Disorders (1 paper). The work is most often cited by research in Oncology (9.4k citations), Immunology (1.7k citations), Cancer Research (655 citations), Pulmonary and Respiratory Medicine (831 citations) and Genetics (205 citations). Grace Cherry has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Bartosz Chmielowski, Antoni Ribas, Willy Hugo, Roger S. Lo, Siwen Hu‐Lieskovan, Jesse Meir Zaretsky, Beata Berent-Maoz, Mark C. Kelley, Douglas Buckner Johnson and Xiangju Kong. Their work appears in journals such as Nature, Cell, Journal for ImmunoTherapy of Cancer, Seminars in Oncology Nursing and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.